Breast Cancer Clinical Trials

Showing 1081-1100 of 4,817 trials

Using a Blood Test to Monitor Metastatic Breast Cancer Treatment

NCT05804578

The goal of this observational study is to assess the effectiveness of the mDETECT breast cancer blood test at monitoring treatment response in women with metastatic breast cancer undergoing treatment.

Metastatic Breast Cancer

Dr. Christopher Mueller150 participantsStarted Oct 2023

Kingston, Ontario, Canada • Toronto, Ontario, Canada

RECRUITINGPhase 1/2

Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer

NCT05491083

This is a phase Ib followed by phase II clinical trial evaluating the safety and efficacy of combination of ADG106 with pembrolizumab in patients with metastatic cancers. The Phase Ib dose finding part will include all solid tumor subtypes with treatment refractory disease, while phase II will focus on only patients with TNBC.

Advanced Solid TumorTriple Negative Breast Cancer

National University Hospital, Singapore51 participantsStarted Jun 2023

Singapore, Singapore

Active Not RecruitingNA

Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer

NCT06019988

The overarching goal of this project is to optimize the collection of social and behavioral determinants of health (SBDOH) for patients with a pathological diagnosis of breast cancer at Penn Medicine. The investigators will measure rates of SBDOH data collection by modality and rates of referral to and uptake of social support services, time to evaluation, staff time, acceptability, patient-centered communication, medical mistrust, and clinician acceptability.

Breast CancerSocial Determinants of Health (SDOH)

Abramson Cancer Center at Penn Medicine2,500 participantsStarted Mar 2024

Philadelphia, Pennsylvania, United States

Using a Blood Test to Monitor Metastatic Breast Cancer Treatment

Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer

Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer

Related Searches

Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia

Copenhagen Master Observational Trial

Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women

To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment

The Effect of Health Education Conducted Using Two Different Methods on Women's Knowledge of Breast Cancer, Health Beliefs, Mammography Self-Efficacy, and Participation in Screening Programs

BAriaTric Surgery After Breast Cancer Treatment (BATS)

Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors

Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity

Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK

Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer

Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer

Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer

Early Detection of Breast Cancer Among Syrian Women

Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors

Electrochemical Biosensor Based on Lectin-functionalized Nitrogen, Sulfur-doped Graphene Quantum Dot Decorated Gold Nanoparticles for Breast Cancer Diagnosis: From Academic Research to Clinical Translation